Distribution of RET mutations in multiple endocrine neoplasia 2 in Denmark 1994-2014: a nationwide study.

Familial MTC with RET exon 8 Gly533Cys mutation: origin and prevalence of second malignancy. Endocr Connect (2017) 0.75

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature (1993) 5.81

Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet (1993) 4.38

A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature (1994) 3.87

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid (2015) 2.67

Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci U S A (1994) 2.25

Mutational spectrum of multiple endocrine neoplasia type 2 and sporadic medullary thyroid carcinoma in taiwan. J Formos Med Assoc (2009) 1.40

Multiple endocrine neoplasia type 2 RET protooncogene database: repository of MEN2-associated RET sequence variation and reference for genotype/phenotype correlations. Hum Mutat (2009) 1.27

Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. Eur J Endocrinol (2010) 1.04

Predominant RET Germline Mutations in Exons 10, 11, and 16 in Iranian Patients with Hereditary Medullary Thyroid Carcinoma. J Thyroid Res (2011) 0.95

RET proto-oncogene genetic screening of families with multiple endocrine neoplasia type 2 optimizes diagnostic and clinical management in China. Thyroid (2012) 0.93

RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B. Clin Endocrinol (Oxf) (2007) 0.92

Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers. Cancer (2002) 0.92

Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective study. Eur J Endocrinol (2001) 0.92

RET proto-oncogene in Sardinia: V804M is the most frequent mutation and may be associated with FMTC/MEN-2A phenotype. Thyroid (2007) 0.90

Molecular analysis of the RET proto-oncogene key exons in patients with medullary thyroid carcinoma: a comprehensive study of the Iranian population. Thyroid (2011) 0.90

RET gene mutations and polymorphisms in medullary thyroid carcinomas in Indian patients. J Biosci (2011) 0.90

Molecular epidemiology of multiple endocrine neoplasia 2: implications for RET screening in the new millenium. Eur J Endocrinol (2013) 0.90

Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patients. J Clin Endocrinol Metab (2001) 0.87

Cys 618 Arg mutation in the RET proto-oncogene associated with familial medullary thyroid carcinoma and maternally transmitted Hirschsprung's disease suggesting a role for imprinting. Hum Mutat (1997) 0.85

Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal. Clin Endocrinol (Oxf) (2006) 0.85

Screening of six risk exons of the RET proto-oncogene in families with medullary thyroid carcinoma in the Czech Republic. J Endocrinol (2004) 0.84

RET proto-oncogene mutations are restricted to codon 634 and 618 in Korean families with multiple endocrine neoplasia 2A. Thyroid (2004) 0.83

Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility. Endocr Relat Cancer (2014) 0.83

RET oncogene mutations in medullary thyroid carcinoma in Mexican families. Arch Med Res (2003) 0.82

High prevalence of the C634Y mutation in the RET proto-oncogene in MEN 2A families in Spain. J Med Genet (1999) 0.82

Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer? Clin Endocrinol (Oxf) (2014) 0.81

Change in the spectrum of RET mutations diagnosed between 1994 and 2006. Clin Lab (2007) 0.81

Genetic screening of patients with medullary thyroid cancer in a referral center in Greece during the past two decades. Eur J Endocrinol (2015) 0.80

The occurrence and the type of germline mutations in the RET gene in patients with medullary thyroid carcinoma and their unaffected kindred's from Central Poland. Cancer Invest (2007) 0.80

Screening of RET gene mutations in Chinese patients with medullary thyroid carcinoma and their relatives. Fam Cancer (2016) 0.80

Codon Y791F mutations in a large kindred: is prophylactic thyroidectomy always indicated? World J Surg (2007) 0.79

Evaluation of the role of RET polymorphisms/haplotypes as modifier loci for MEN 2, and analysis of the correlation with the type of RET mutation in a series of Spanish patients. Int J Mol Med (2006) 0.78

Is thyroidectomy necessary in RET mutations carriers of the familial medullary thyroid carcinoma syndrome? Cancer (2000) 0.78

Hereditary medullary thyroid cancer in Slovenia--genotype-phenotype correlations. Wien Klin Wochenschr (2006) 0.77

Primary diagnosis of multiple pheochromocytomas in the brother of a MEN-2 patient by simultaneous MIBG scintigraphy and low-dose computed tomography. Clin Nucl Med (2002) 0.77

Molecular genetic diagnostic program of multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma syndromes in Hungary. J Endocrinol (2001) 0.77

Screening for hereditary medullary cancer in Denmark. Henry Ford Hosp Med J (1984) 0.77

RET codon 618 mutations in Saudi families with multiple endocrine neoplasia Type 2A and familial medullary thyroid carcinoma. Ann Saudi Med (2013) 0.76

Aggressive medullary thyroid carcinoma in a ten-year-old patient with multiple endocrine neoplasia 2B due to the A883F mutation. Thyroid (2015) 0.76

RET proto-oncogene mutations are restricted to codon 618 in Cypriot families with multiple endocrine neoplasia 2. J Endocrinol Invest (2011) 0.76

MEN 2A families: from hot spots to hot regions. Int J Mol Med (2003) 0.76

[Medullary thyroid carcinoma in a 10-month-old child with multiple endocrine neoplasia 2B]. Ugeskr Laeger (2014) 0.76

Medullary thyroid cancer: RET testing of an archival material. Eur Arch Otorhinolaryngol (2009) 0.76

Choroidal metastases in multiple endocrine neoplasia type 2B. Acta Ophthalmol Scand (2007) 0.76

Rapid MEN 2A gene carrier identification using primer-specific PCR amplification. Scand J Clin Lab Invest (1999) 0.76